Saul Barker

Saul Barker has several years of experience in financial planning and analysis. Saul worked as the Head of Financial Planning & Analysis at Swissport from January 2018 onwards, where they led the planning process, provided detailed variance analysis, and developed the core reporting system. Prior to that, they held various roles at AstraZeneca from October 2014 to December 2017, including Lead Finance Manager, Finance Transition Lead, and Senior Business Analyst. At AstraZeneca, they focused on driving cost savings, simplification, and standardization, as well as budgeting and forecasting. Before their time at AstraZeneca, Saul worked at JTI (Japan Tobacco International), where they held positions as Opex Initiatives Lead and Senior FP&A Manager. In these roles, they led financial analysis, focused on cost management and sustainability, and played a key role in achieving significant cost savings.

Saul Barker attended Loughborough University from 1994 to 1997, where they obtained a BSC (Hons.) degree in Accountancy and Financial Management. The program encompassed accountancy and general business studies, including marketing, HR, and finance. Prior to that, they attended the University of South Wales from 1992 to 1994, where they earned a Higher National Diploma in Business and Finance. Additionally, Saul Barker holds a certification as a Chartered Global Management Accountant (CGMA) from CIMA, although the specific details regarding its acquisition are not provided.